Citadel Advisors - HORIZON THERAPEUTICS PUB L ownership

HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of HORIZON THERAPEUTICS PUB L
ValueSharesWeighting
Q3 2023$654,727,310
-1.6%
5,659,325
-12.6%
0.14%
+1.4%
Q2 2023$665,696,728
+51.8%
6,472,501
+61.1%
0.14%
+43.8%
Q1 2023$438,547,330
+80.8%
4,018,209
+88.5%
0.10%
+68.4%
Q4 2022$242,603,392
+32.3%
2,131,840
-28.0%
0.06%
+39.0%
Q3 2022$183,313,000
+260.4%
2,961,934
+364.5%
0.04%
+215.4%
Q2 2022$50,864,000
+23.1%
637,709
+62.4%
0.01%
+44.4%
Q1 2022$41,323,000
-73.2%
392,766
-72.5%
0.01%
-71.0%
Q4 2021$154,186,000
-32.4%
1,430,827
-31.3%
0.03%
-35.4%
Q3 2021$228,057,000
+28.2%
2,081,949
+9.6%
0.05%
+23.1%
Q2 2021$177,885,000
+47.7%
1,899,663
+45.2%
0.04%
+30.0%
Q1 2021$120,410,000
+75.5%
1,308,233
+39.4%
0.03%
+66.7%
Q4 2020$68,629,000
-41.7%
938,190
-38.1%
0.02%
-45.5%
Q3 2020$117,720,000
-44.1%
1,515,457
-60.0%
0.03%
-56.6%
Q2 2020$210,567,000
+92.3%
3,788,550
+2.5%
0.08%
+55.1%
Q1 2020$109,503,000
+100.7%
3,696,952
+145.3%
0.05%
+113.0%
Q4 2019$54,551,000
+227.9%
1,506,925
+146.7%
0.02%
+187.5%
Q3 2019$16,634,000
-46.8%
610,865
-53.0%
0.01%
-46.7%
Q2 2019$31,263,0001,299,3710.02%
Other shareholders
HORIZON THERAPEUTICS PUB L shareholders Q1 2022
NameSharesValueWeighting ↓
Kopp Family Office, LLC 544,835$57,322,00030.98%
Paulson & Co. 5,614,000$590,649,00018.18%
Avoro Capital Advisors LLC 6,500,000$683,865,00012.48%
1492 Capital Management LLC 121,840$12,819,0006.80%
Iron Triangle Partners LP 503,744$52,999,0006.30%
Tri Locum Partners LP 132,332$13,923,0005.44%
HealthCor Management, L.P. 710,110$74,711,0004.98%
Eversept Partners, LP 609,939$64,171,6824.93%
Bain Capital Public Equity Management II, LLC 1,286,371$135,339,0004.33%
PFM Health Sciences, LP 1,091,840$114,872,0004.30%
View complete list of HORIZON THERAPEUTICS PUB L shareholders